Imatinib induces mitochondria‐dependent apoptosis of the Bcr‐Abl‐positive K562 cell line and its differentiation toward the erythroid lineage 1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  The FASEB Journal

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.03-0322PMID 14597677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advancements in the treatment of chronic myelogenous leukemia.

  2002cited by this paper
• Nuclear transcription factor GATA‐1 is activated during aclacinomycin‐induced erythroid differentiation

  2002cited by this paper
• Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis.

  2002cited by this paper
• Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

  2002cited by this paper
• Hematopoietic cytokines, transcription factors and lineage commitment

  2002cited by this paper
• Expression of insulin-like growth factors IGF-I and IGF-II, and their receptors during the growth and megakaryocytic differentiation of K562 cells.

  2002cited by this paper
• The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages.

  2002cited by this paper
• The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and postranscriptional regulation

  2002cited by this paper
• Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.

  2002cited by this paper
• Chronic myelogenous leukemia: mechanisms underlying disease progression

  2002cited by this paper
• Bcr-Abl variants: biological and clinical aspects.

  2002cited by this paper
• Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation.

  2002cited by this paper
• Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.

  2002cited by this paper
• BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations

  2002cited by this paper
• An absolute requirement for Fyn in T cell receptor‐induced caspase activation and apoptosis

  2001cited by this paper
• Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition.

  2001cited by this paper
• Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells.

  2001cited by this paper
• Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells.

  2001cited by this paper
• Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation

  2001cited by this paper
• Protein Kinase C Regulates FADD Recruitment and Death-inducing Signaling Complex Formation in Fas/CD95-induced Apoptosis*

  2001cited by this paper
• Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.

  2001cited by this paper
• Molecular and Transcriptional Regulation of Megakaryocyte Differentiation

  2001cited by this paper
• Extracellular Signal-regulated Kinase/90-kDa Ribosomal S6 Kinase/Nuclear Factor-κB Pathway Mediates Phorbol 12-Myristate 13-Acetate-induced Megakaryocytic Differentiation of K562 Cells*

  2001cited by this paper
• Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.

  2000cited by this paper
• CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs.

  2000cited by this paper
• Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1*

  2000cited by this paper
• The molecular biology of chronic myeloid leukemia.

  2000cited by this paper
• Mouse models in the study of the Ets family of transcription factors

  2000cited by this paper
• Sustained Polymorphonuclear Leukocyte Transmigration Induces Apoptosis in T84 Intestinal Epithelial Cells

  2000cited by this paper
• FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells

  2000cited by this paper
• Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase.

  1999cited by this paper
• Reelin is a ligand for lipoprotein receptors.

  1999cited by this paper
• In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor.

  1999cited by this paper
• Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.

  1999cited by this paper
• Cleavage and relocation of the tyrosine kinase P59FYN during Fas-mediated apoptosis in T lymphocytes

  1999cited by this paper
• Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells

  1999cited by this paper
• Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin

  1998cited by this paper
• Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.

  1998cited by this paper
• Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.

  1998cited by this paper
• T-Cell receptor signaling pathway exerts a negative control on thrombin-mediated increase in [Ca2+]i and p38 MAPK activation in Jurkat T cells: implication of the tyrosine kinase p56Lck.

  1998cited by this paper
• The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells.

  1997cited by this paper
• Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase

  1997cited by this paper
• Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells

  1996cited by this paper
• Mitochondrial permeability transition is a central coordinating event of apoptosis

  1996cited by this paper
• Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.

  1996cited by this paper
• Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

  1996cited by this paper
• PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl.

  1996cited by this paper
• PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl

  1996cited by this paper
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

  1996cited by this paper
• The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway.

  1996cited by this paper
• Cortical development: view from neurological mutants two decades later.

  1995cited by this paper
• A protein related to extracellular matrix proteins deleted in the mouse mutant reeler

  1995cited by this paper
• Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo

  1995cited by this paper
• Bcr‐Abl oncoproteins bind directly to activators of the Ras signalling pathway.

  1994cited by this paper
• BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.

  1994cited by this paper
• BCR-ABL Maintains Resistance of Chronic Myelogenous Leukemia Cells to Apoptotic Cell Death

  1994cited by this paper
• Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia.

  1993cited by this paper
• Induced cell surface expression of functional α2β1 integrin during megakaryocytic differentiation of K562 leukemic cells

  1992cited by this paper
• Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells.

  1992cited by this paper
• Differential regulation of the alpha 2 beta 1 and alpha IIb beta 3 integrin genes during megakaryocytic differentiation of pluripotential K562 cells.

  1992cited by this paper
• BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.

  1991cited by this paper
• Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

  1990cited by this paper
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

  1973cited by this paper
• A minute chromosome in human chronic granulocytic leukemia

  1960cited by this paper
• rapid communication Identification and characterization of LRP8 (apoER2) in human blood platelets

  year unknowncited by this paper

• Exploring the main source of coproporphyrins: Observations on transport in red blood cells.

  2025cites this paper
• Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinib

  2025cites this paper
• Toxicity evaluation of laser-synthesized pro-angiogenic carbon monoxide-rich gold nanoparticles in vitro and in vivo

  2025cites this paper
• Sparking angiogenesis by carbon monoxide-rich gold nanoparticles obtained by pulsed laser driven CO2 reduction reaction

  2025cites this paper
• Nanosensors in Leukemia Management: Pioneering Real‐Time Biomarker Detection for Precision Oncology

  2025cites this paper
• Tackling Imatinib Resistance via Au‐nanoconjugates using A Cml Resistant Cell Line

  2023cites this paper
• The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation

  2022cites this paper
• Combination therapy using TGF-β1 and STI-571 can induce apoptosis in BCR-ABL oncogene-expressing cells

  2021cites this paper
• Expression of inducible NOS is indispensable for the antiproliferative and proapoptotic effect of imatinib in BCR–ABL positive cells

  2021cites this paper
• Evaluation of the anticancer activity of dipyridamole and Imatinib mesylate compounds against breast cancer cell line and related biochemical and genetic changes

  2021cites this paper
• Pharmacokinetics study of potential anti-CML drug Cyclobentinib (CB1107) by HPLC–MS/MS

  2021cites this paper
• ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins

  2021cites this paper
• CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

  2021cites this paper
• Ultra-small platinum nanoparticles on gold nanorods induced intracellular ROS fluctuation to drive megakaryocytic differentiation of leukemia cells.

  2020cites this paper
• Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma.

  2020cites this paper
• CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene in chronic myeloid leukemia and restores normal hematopoiesis

  2020cites this paper
• Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling.

  2020cites this paper
• Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia

  2019cites this paper
• Continuous cytostatic effects of BCR-ABL tyrosine kinase inhibitors (TKIs) after washout in human leukemic K562 cells.

  2019cites this paper
• Inorganic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myelogenous Leukaemia

  2019cites this paper
• Imatinib modulates pro-inflammatory microenvironment with angiostatic effects in experimental lung carcinogenesis

  2019cites this paper
• High-level embryonic globin production with efficient erythroid differentiation from a K562 erythroleukemia cell line.

  2018cites this paper
• C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation

  2018cites this paper
• Consensus Predictive Model for Human K562 Cell Growth Inhibition through Enalos Cloud Platform

  2018cites this paper
• CANCER THERAPY

  2018cites this paper
• Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia

  2017cites this paper
• Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients

  2017cites this paper
• Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway

  2017cites this paper
• Investigating the effect of insect conditioned medium and its constituents on the terminal differentiation of leukaemia

  2017cites this paper
• Allium Roseum L. Extract Exerts Potent Suppressive Activities on Chronic Myeloid Leukemia K562 Cell Viability Through the Inhibition of BCR-ABL, PI3K/Akt, and ERK1/2 Pathways and the Abrogation of VEGF Secretion

  2017influential citation
• Nonneuronal roles for the reelin signaling pathway

  2017cites this paper
• Ecotropic viral integration site I regulates alpha1, 6-fucosyl transferase expression and blocks erythropoiesis in chronic myeloid leukemia

  2017cites this paper
• In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies.

  2017cites this paper
• Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes

  2017cites this paper
• A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells

  2017cites this paper
• Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines

  2017cites this paper
• Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors.

  2017cites this paper
• Induction of GD3/α1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells

  2017cites this paper
• Apoptosis gene network regulated by delta-tocotrienol in K562 chronic myeloid leukaemia cells

  2017cites this paper
• Hemin induces mitophagy in a leukemic erythroblast cell line

  2016cites this paper
• In Vitro Cytotoxic and Proapoptotic Activities of Anatolian Macrovipera Lebetina Obtusa (Dwigubski, 1832) Crude Venom on Cultured K562 Human Chronic Myelogenous Leukemia Cells.

  2016cites this paper
• Cytotoxic Activity of Mangosteen ( Garcinia mangostana L.) Peel Extract and α-mangostin toward Leukemia Cell Lines (HL-60 and K-562)

  2016cites this paper
• Armillaridin induces autophagy-associated cell death in human chronic myelogenous leukemia K562 cells

  2016cites this paper
• Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death

  2016cites this paper
• Up regulation of KAI1 gene expression and apoptosis effect of imatinib mesylate in gastric adenocarcinoma (AGS) cell line

  2016cites this paper
• Identification de microARN impliqués dans la leucémogenèse

  2016cites this paper
• Rôle de la signalisation calcique dans la leucémie myéloïde chronique

  2016cites this paper
• ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia

  2016cites this paper
• Title Identification of small molecules that disrupt signaling between ABL and its positive regulator RIN 1 Permalink

  2015cites this paper
• Imatinib induces down-regulation of Bcl-2 an anti-apoptotic protein in prostate cancer PC-3 cell line

  2015cites this paper
• Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells

  2015cites this paper
• Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition.

  2015cites this paper
• Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells

  2015cites this paper
• Identification of Small Molecules that Disrupt Signaling between ABL and Its Positive Regulator RIN1

  2015cites this paper
• BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia

  2014cites this paper
• Thioaryl naphthylmethanone oxime ether analogs as novel anticancer agents.

  2014cites this paper
• Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.

  2014cites this paper
• Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

  2014cites this paper
• Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

  2014cites this paper
• Erythroid differentiation is augmented in Reelin‐deficient K562 cells and homozygous reeler mice

  2014cites this paper
• Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection

  2013cites this paper
• Effects of radiation on the maturation of megakaryocytes

  2013cites this paper
• Factor plasma level in patients with Chronic Myeloid Leukemia Imatinib Mesylate (STI571) decreases the Vascular Endothelial Growth

  2013cites this paper
• Synergistic effect of hydrogen peroxide on polyploidization during the megakaryocytic differentiation of K562 leukemia cells by PMA.

  2013cites this paper
• Molecularly-targeted anti-cancer drug interactions of the human ABCG2 multidrug transporter

  2013cites this paper
• N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention

  2013cites this paper
• Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway

  2012cites this paper
• A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.

  2012cites this paper
• A potential role of fetal hemoglobin in the development of multidrug resistance.

  2012cites this paper
• All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib

  2012cites this paper
• Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells.

  2012cites this paper
• Imatinib treatment inhibit IL‐6, IL‐8, NF‐KB and AP‐1 production and modulate intracellular calcium in CML patients

  2012cites this paper
• Autophagy induction by Bcr‐Abl‐expressing cells facilitates their recovery from a targeted or nontargeted treatment

  2011cites this paper
• Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells

  2011cites this paper
• Intrinsic Mechanisms that Regulate T Cell Homeostasis and Function

  2011cites this paper
• 2‐D gel electrophoresis‐based proteomic analysis reveals that ormeloxifen induces G0–G1 growth arrest and ERK‐mediated apoptosis in chronic myeloid leukemia cells K562

  2011cites this paper
• A New Hydroxylated Nonaprenylhydroquinone from the Mediterranean Marine Sponge Sarcotragus spinosulus

  2011cites this paper
• Long Circulating Lectin Conjugated Paclitaxel Loaded Magnetic Nanoparticles: A New Theranostic Avenue for Leukemia Therapy

  2011influential citation
• α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells.

  2011cites this paper
• Regulation of T‐cell survival and mitochondrial homeostasis by TSC1

  2011cites this paper
• The effect of N-acetylcysteine on the antitumor activity of ifosfamide.

  2011cites this paper
• Pyrrolo[1,2‐b][1,2,5]benzothiadiazepines (PBTDs) exert their anti‐proliferative activity by interfering with Akt–mTOR signaling and bax:bcl‐2 ratio modulation in cells from chronic myeloid leukemic patients

  2010cites this paper
• Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib.

  2010cites this paper
• Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2

  2010cites this paper
• Global proteome quantification for discovering imatinib-induced perturbation of multiple biological pathways in K562 human chronic myeloid leukemia cells.

  2010cites this paper
• Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR–ABL cleavage and elimination of chronic myelogenous leukemia cells

  2010cites this paper
• Carvedilol in glioma treatment alone and with imatinib in vitro.

  2010cites this paper
• Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.

  2010cites this paper
• The Therapeutic Potential of Lentivector-delivered RNAi

  2010cites this paper
• The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562.

  2010cites this paper
• Tautomerization of 2-nitroso-N-arylanilines by coordination as N,N'-chelate ligands to rhenium(I) complexes and the anticancer activity of newly synthesized oximine rhenium(I) complexes against human melanoma and leukemia cells in vitro.

  2010cites this paper
• Hemin counteracts the repression of Bcl-2 and NrF2 genes and the cell killing induced by imatinib in human Bcr-Abl(+) CML cells.

  2009cites this paper
• Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors

  2009cites this paper
• PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells*

  2009cites this paper
• Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line

  2009cites this paper
• Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death

  2009cites this paper
• Downregulation of uridine-cytidine kinase like-1 decreases proliferation and enhances tumor susceptibility to lysis by apoptotic agents and natural killer cells

  2009cites this paper
• A non‐apoptotic function of caspase‐3 in pharmacologically‐induced differentiation of K562 cells

  2009cites this paper
• Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells

  2009cites this paper
• C3G silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival.

  2009cites this paper